Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Regen Biopharma Inc (RGBPP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0410 +17.07%
on 02/02/18
0.0580 -17.24%
on 02/02/18
-0.0020 (-4.00%)
since 01/19/18
3-Month
0.0410 +17.07%
on 02/02/18
0.0900 -46.67%
on 11/21/17
-0.0180 (-27.27%)
since 11/20/17
52-Week
0.0200 +140.00%
on 07/31/17
0.0900 -46.67%
on 11/21/17
-0.0274 (-36.34%)
since 02/17/17

Most Recent Stories

More News
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) continues to develop small molecule drugs that activate NR2F6 and has identified a key structural element whose presence in small molecules seems to...

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6

SAN DIEGO , January 17, 2018 /PRNewswire/ --

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Regen BioPharma, Inc. Files Additional Composition of Matter Patent Application on NR2F6-Modulating Small Molecules

Regen BioPharma, Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) today announced filing a patent application covering composition of matter and methods of use related to molecules identified in its small molecule...

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Regen BioPharma, Inc. Files Additional Composition of Matter Patent Application on NR2F6-Modulating Small Molecules

SAN DIEGO , December 11, 2017 /PRNewswire/ --

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Regen BioPharma, Inc. Begins In Vivo Assessment of Small Molecule Agonists to NR2F6 Nuclear Receptor

SAN DIEGO, California , November 27, 2017 /PRNewswire/ --

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Regen BioPharma, Inc. Begins In Vivo Assessment of Small Molecule Agonists to NR2F6 Nuclear Receptor

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) has initiated in vivo and ex vivo assessments to determine the effects of some of the Company's NR2F6 small molecule agonists in live rats and in tissues...

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Regen BioPharma Inc. Chairman Discusses the Rationale for Pursuing Autoimmune Indications by Activating the Nuclear Receptor NR2F6

SAN DIEGO , November 16, 2017 /PRNewswire/ --

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Regen BioPharma Inc. Chairman Discusses the Rationale for Pursuing Autoimmune Indications by Activating the Nuclear Receptor NR2F6

18 months ago, Regen BioPharma Inc. (OTCQB: RGBP)(OTCQB: RGBPP) commenced a program to identify small molecules that inhibit the NR2F6 nuclear receptor. The NR2F6 nuclear receptor has been identified as...

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
Cancer Immunotherapy Technology Projected to Create Further Growth

According to data provided by Allied Market Research, the global cancer immunotherapy market is expected to grow to $117.14 billion by 2022, growing at a CAGR of 14.5 percent from the time period of 2016...

CLDX : 2.38 (+1.28%)
ARQL : 1.68 (-2.33%)
RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)
ECYT : 3.57 (+12.26%)
CASI : 3.79 (-1.30%)
Regen BioPharma's Chief Scientific Officer Explains the Link Between its NR2F6 Medicinal Chemistry and Three-Dimensional X-Ray Structure Programs

SAN DIEGO , November 8, 2017 /PRNewswire/ --

RGBP : 0.0449 (unch)
RGBPP : 0.0480 (-4.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Key Turning Points

2nd Resistance Point 0.0518
1st Resistance Point 0.0512
Last Price 0.0480
1st Support Level 0.0502
2nd Support Level 0.0498

See More

52-Week High 0.0900
Fibonacci 61.8% 0.0633
Fibonacci 50% 0.0550
Last Price 0.0480
Fibonacci 38.2% 0.0467
52-Week Low 0.0200

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.